Welcome to CURA

Let's configure your regulatory intelligence workspace.

Are you an HCP or a manufacturer?

Select your primary role in the healthcare ecosystem.

Login

Clinical Trials & Lifecycle Monitor

Global tracking of registered clinical trials (Phase I-IV), outcome safety dockets, patient enrollment velocities, and therapeutic whitespace matrices to identify breakthrough development opportunities.

INTELLIGENT PIPELINE FILTERS
Ingested Clinical Trials Stream (20 trials mapping)Validated
NCT04078230• Phase: NA• Second Affiliated Hospital, Zhejiang University, School of Medicine

Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma

Therapeutic Target

Extend LymphAdenectomy

Disease Category

Intrahepatic Cholangiocarcinoma

Study Start Date

2020-01-01

Enrollment Ratio

168 / 168 (100%)

Recruitment StatusRECRUITING
No structural risk alarms
NCT07036328• Phase: NA• Willem de Haan

Transcranial Magnetic Stimulation to Slow Down Cognitive Decline in Alzheimer's Disease

Therapeutic Target

repetitive transcranial magnetic stimulation

Disease Category

Alzheimer Disease

Study Start Date

2025-04-07

Enrollment Ratio

55 / 55 (100%)

Recruitment StatusRECRUITING
No structural risk alarms
NCT06828328• Phase: EARLY_PHASE1• Shanghai Juncell Therapeutics

A Study of GC203 TIL in PDCA (RJ)

Therapeutic Target

GC203 TIL

Disease Category

Pancreatic Cancer

Study Start Date

2025-02-10

Enrollment Ratio

10 / 10 (100%)

Recruitment StatusRECRUITING
Advisory: Low Enrollment Rate
NCT06413667• Phase: Not Applicable• Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Assessment of the Alignment of the Atlas and Surrounding Tissues in Chronic Whiplash Associated Disorder

Therapeutic Target

N/A

Disease Category

Chronic Whiplash Associated Disorder

Study Start Date

2024-04-08

Enrollment Ratio

90 / 90 (100%)

Recruitment StatusRECRUITING
No structural risk alarms
NCT05856565• Phase: Not Applicable• Nantes University Hospital

Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Predictive Factor of Response to Anti-PD-1

Therapeutic Target

Photo

Disease Category

Metastatic Melanoma

Study Start Date

2023-07-24

Enrollment Ratio

700 / 700 (100%)

Recruitment StatusRECRUITING
No structural risk alarms
NCT06875765• Phase: NA• Universitaire Ziekenhuizen KU Leuven

Long-term Longitudinal Imaging of Presynaptic Terminals in PD

Therapeutic Target

11C-UCB-J PET-CT

Disease Category

Parkinson Disease

Study Start Date

2025-07-16

Enrollment Ratio

35 / 35 (100%)

Recruitment StatusRECRUITING
Advisory: Low Enrollment Rate
NCT06280807• Phase: Not Applicable• National Institute of Environmental Health Sciences (NIEHS)

Observation of Environment and Reproductive-Endocrine Effects

Therapeutic Target

N/A

Disease Category

Hypogonadism

Study Start Date

2024-07-01

Enrollment Ratio

300 / 300 (100%)

Recruitment StatusRECRUITING
No structural risk alarms
NCT06738407• Phase: PHASE4• Westat

Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections

Therapeutic Target

Doxycycline hyclate delayed released 200 mg

Disease Category

Gonorrhea

Study Start Date

2026-02-27

Enrollment Ratio

760 / 760 (100%)

Recruitment StatusRECRUITING
No structural risk alarms
NCT04092192• Phase: NA• University of Chicago

Forceps vs. Snare IVC Filter Removal

Therapeutic Target

IVC filter removal

Disease Category

DVT

Study Start Date

2018-12-26

Enrollment Ratio

100 / 100 (100%)

Recruitment StatusRECRUITING
No structural risk alarms
NCT00900471• Phase: Not Applicable• Wake Forest University Health Sciences

Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors

Therapeutic Target

biologic sample preservation procedure

Disease Category

Unspecified Adult Solid Tumor, Protocol Specific

Study Start Date

2004-04-01

Enrollment Ratio

20000 / 20000 (100%)

Recruitment StatusRECRUITING
No structural risk alarms
NCT06933134• Phase: Not Applicable• University Hospital, Tours

Prospective Validation of a Pharmacological Biomarker for Low-Dose Rituximab in Rheumatoid Arthritis

Therapeutic Target

N/A

Disease Category

Rheumatoid Arthritis (RA)

Study Start Date

2026-04-23

Enrollment Ratio

30 / 30 (100%)

Recruitment StatusRECRUITING
Advisory: Low Enrollment Rate
NCT07064434• Phase: NA• General Hospital of Ningxia Medical University

Sacral Canal Block for Hip Replacement the Efficacy and Safety of Controlled Intraoperative Hypotension

Therapeutic Target

Sacral canal block combined with general anesthesia

Disease Category

Postoperative Pain

Study Start Date

2024-11-01

Enrollment Ratio

80 / 80 (100%)

Recruitment StatusRECRUITING
No structural risk alarms
NCT07025434• Phase: NA• Dominican University New York

Effects of Hip Bump Manipulation Versus Sham Treatment in Healthy Adults

Therapeutic Target

Hip Bump Manipulation

Disease Category

Assessment of Hip Strength, Range of Motion, EMG Activation, and Landing Mechanics in Healthy Subjects

Study Start Date

2025-06-20

Enrollment Ratio

60 / 60 (100%)

Recruitment StatusRECRUITING
No structural risk alarms
NCT06998264• Phase: Not Applicable• University Hospital, Geneva

In-depth Analysis of the Immune Responses in the Upper Respiratory Tract of Influenza-infected Children

Therapeutic Target

N/A

Disease Category

Influenza Infection

Study Start Date

2025-03-04

Enrollment Ratio

40 / 40 (100%)

Recruitment StatusRECRUITING
Advisory: Low Enrollment Rate
NCT04288999• Phase: PHASE3• National Cancer Center Hospital East

Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer

Therapeutic Target

Chemotherapy

Disease Category

Rectal Cancer Recurrent

Study Start Date

2019-10-01

Enrollment Ratio

110 / 110 (100%)

Recruitment StatusRECRUITING
No structural risk alarms
NCT06393699• Phase: NA• Ain Shams University

Restoration of Non-carious Cervical Lesions With Different Resin Composites and Universal Adhesive

Therapeutic Target

composite restoration

Disease Category

Retention

Study Start Date

2022-05-14

Enrollment Ratio

52 / 52 (100%)

Recruitment StatusRECRUITING
No structural risk alarms
NCT06886932• Phase: Not Applicable• Elif Dilara Durmaz

Pain Education After Rotator Cuff Surgery

Therapeutic Target

N/A

Disease Category

Rotator Cuff Tears

Study Start Date

2025-04-01

Enrollment Ratio

45 / 45 (100%)

Recruitment StatusRECRUITING
Advisory: Low Enrollment Rate
NCT07703332• Phase: NA• University of Faisalabad

Elongation Longitudinal Decoaptation Ostéo-Articulaire Versus Active Isolated Stretching on Median Nerve Mobility and Pain in Patient With Upper Limb Overuse Syndrome

Therapeutic Target

Elongation longitudinal decoaptation ostéo-articulaire (ELDOA) and baseline

Disease Category

Upper Limb Overuse Syndrome

Study Start Date

2026-07-10

Enrollment Ratio

84 / 84 (100%)

Recruitment StatusRECRUITING
No structural risk alarms
NCT04584632• Phase: NA• Efemoral Medical, Inc.

The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery

Therapeutic Target

Efemoral Vascular Scaffold System (EVSS)

Disease Category

Peripheral Arterial Disease

Study Start Date

2020-09-22

Enrollment Ratio

100 / 100 (100%)

Recruitment StatusRECRUITING
No structural risk alarms
NCT04025398• Phase: NA• Hôpital le Vinatier

A Computer-based Cognitive Remediation Program for Adults With Intellectual Disability

Therapeutic Target

Cognitive remediation program

Disease Category

Intellectual Disability

Study Start Date

2020-06-17

Enrollment Ratio

116 / 116 (100%)

Recruitment StatusRECRUITING
No structural risk alarms